Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 20,079 | 15,430 | 12,104 | 9,899 | 10,409 |
| Operating Income | -20,079 | -15,430 | -12,104 | -9,899 | -10,409 |
| Other Income | 52 | -358 | 16 | 224 | -506 |
| Pre-tax Income | -20,027 | -15,788 | -12,088 | -9,675 | -10,915 |
| Net Income Continuous | -20,027 | -15,788 | -12,088 | -9,675 | -10,915 |
| Net Income | $-20,027 | $-15,788 | $-12,088 | $-9,675 | $-10,915 |
| EPS Basic Total Ops | -0.88 | -0.78 | -1.30 | -0.72 | -1.06 |
| EPS Basic Continuous Ops | -0.83 | -0.72 | -0.72 | -0.64 | -0.91 |
| EPS Diluted Total Ops | -0.88 | -0.78 | -1.30 | -0.72 | -1.06 |
| EPS Diluted Continuous Ops | -0.83 | -0.72 | -0.72 | -0.64 | -0.91 |
| EBITDA(a) | $-20,072 | $-15,420 | $-12,092 | $-9,890 | $-10,400 |